Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients

By Strojan P.   Budihna M.   S   mid L.   Vrhovec I.   S   krk J.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1193-1197

Elsevier

Access to resources Recommend Favorite

Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients

By Grøndahl-Hansen J.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 2, 1997-04 ,pp. : 153-163

Springer Publishing Company

Access to resources Recommend Favorite

Immunoassays (ELISA) of Urokinase-type Plasminogen Activator (uPA): Report of an EORTC/BIOMED-1 Workshop

By Benraad T.J.   Geurts-Moespot J.   Grondahl-Hansen J.   Schmitt M.   Heuvel J.J.T.M.   de Witte J.H.   Foekens J.A.   Leake R.E.   Brunner N.   Sweep C.G.J.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1371-1381

Elsevier

Access to resources Recommend Favorite

Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome

By Witzel Isabell   Milde-Langosch Karin   Wirtz Ralph   Roth Claudia   Ihnen Maike   Mahner Sven   Zu Eulenburg Christine   Jänicke Fritz   Müller Volkmar  

Journal of Cancer Research and Clinical Oncology, Vol. 136, Iss. 11, 2010-11 ,pp. : 1709-1718

Springer Publishing Company

Access to resources Recommend Favorite

uPA/PAI-1 expression and uPA promoter methylation in meningiomas

By Kandenwein Julia   Park-Simon Tjoung-Won   Schramm Johannes   Simon Matthias  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 533-539

Springer Publishing Company

Access to resources Recommend Favorite